For QA and regulatory

ICH M7 assessment takes weeks, nitrosamine risk without a fast first picture.

Here is what that path looks like today, and what it looks like with validated tools inside your AI assistant.

Today

The ICH M7 assessment passes through several hands and several weeks.
Structural alerts get looked up, the rationale is written by hand.
On a nitrosamine suspicion the fast first picture is missing.
For the inspection you must show how an assessment came about.

With CovaSyn

ICH M7 mutagenicity screening returns a first classification including structural alerts.
Suspect impurities are checked against mass spectra and fragment annotation.
Triage says early what is harmless and what needs a real assessment.
Input, tool version, configuration and result are logged for every call.

The assessment stays yours. CovaSyn provides the first pass and the trail that keeps it traceable.

The tools behind it

Covatox

24 functions

ICH M7 mutagenicity screening, Tox21, CYP450, structural alerts, ADMET triage.

Covams

29 functions

Mass spectra, formula prediction, fragment annotation, impurity profiling.

Independent benchmark · ICLR 2026

Frontier LLMs reach 14 to 41 percent on chemistry. With CovaSyn MCP attached: 76 to 92 percent.

Peer-reviewed MolecularIQ benchmark (ICLR 2026). 3,540 verified chemistry tasks, four frontier models. Three reach 85 to 92 %; the cheapest (Gemini 3.5 Flash) lands at 76 %.

Create an account and try the tools right away. No credit card.